Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-23-017566
Filing Date
2023-05-15
Accepted
2023-05-15 17:28:23
Documents
15

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 989223
2 ex3-4.htm EX-3.4 4320
3 ex23-1.htm EX-23.1 7274
4 ex23-2.htm EX-23.2 1044
5 forms-1a_001.jpg GRAPHIC 280479
6 aud_001.jpg GRAPHIC 2879
7 ex3-4_001.jpg GRAPHIC 240844
8 ex3-4_002.jpg GRAPHIC 527824
9 ex3-4_003.jpg GRAPHIC 384928
10 ex3-4_004.jpg GRAPHIC 426810
11 ex3-4_005.jpg GRAPHIC 375182
12 ex3-4_006.jpg GRAPHIC 59212
13 ex23-1_001.jpg GRAPHIC 11061
14 ex23-1_002.jpg GRAPHIC 3903
15 ex23-3_001.jpg GRAPHIC 97219
  Complete submission text file 0001493152-23-017566.txt   4323519
Mailing Address 200 CANAL VIEW BLVD SUITE 104 ROCHESTER NY 14623
Business Address 200 CANAL VIEW BLVD SUITE 104 ROCHESTER NY 14623 585 232 1500
IMPACT BIOMEDICAL INC. (Filer) CIK: 0001834105 (see all company filings)

EIN.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-253037 | Film No.: 23924568
SIC: 2834 Pharmaceutical Preparations